Guimin Xia
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Identification of the target ANTXR1 and covalent acylation mechanism of 8-esterified cycloberberines against cancer.
Journal: European journal of medicinal chemistry
Published: December 29, 2025
Mitophagy and Bip-PERK-eIF2α-ATF4 Axis-Mediated ER Stress Mediate Miriplatin-Loaded Liposome's Anti-Colorectal Cancer Action.
Journal: Cell proliferation
Published: April 14, 2025
Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targets.
Journal: Hepatology (Baltimore, Md.)
Published: August 22, 2024
Improved Antitumor Efficiency of N4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy.
Journal: International journal of nanomedicine
Published: July 07, 2024
Strategies to Promote the Journey of Nanoparticles Against Biofilm-Associated Infections.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: July 17, 2023
Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 24, 2023
Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication.
Journal: Acta pharmaceutica Sinica. B
Published: April 19, 2023
Enhanced binding of β-catenin and β-TrCP mediates LMPt's anti-CSCs activity in colorectal cancer.
Journal: Biochemical pharmacology
Published: January 14, 2023
Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 22, 2021
Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
Journal: Bioorganic & medicinal chemistry
Published: May 25, 2021
Last Updated: 09/26/2026